Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
KaLy-Cell is a specialized contract research organization (CRO) that provides high-quality in vitro services for the pharmaceutical, cosmetic, and chemical industries. Based in France, the company is a recognized leader in the isolation, cryopreservation, and characterization of hepatocytes from various animal species and humans. Their service portfolio focuses on drug metabolism and pharmacokinetics (DMPK), including metabolic stability, metabolite profiling, and drug-drug interaction (DDI) studies. Additionally, KaLy-Cell offers advanced toxicology assessments, such as hepatotoxicity testing using 2D and 3D cell culture models. By providing both standardized and customized assays, the company supports researchers in early-stage drug discovery and safety evaluation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KaLy-Cell.